A Narrative Review of FDA Human Factors Validation Requirement: The Needs of Key Stakeholders and Proposal of an Industry (Human Factors Service Providers) Maturity Assessment Tool

Abstract

As part of a comprehensive Quality System Regulation (QSR), the human factors (HF) validation requirement by the Food and Drug Administration (FDA) is a relatively recent topic. Multiple issues and bottlenecks have emerged since the publication of the draft guidance in 2011. The scientific literature on the topic of ‘FDA HF validation requirement’ is mostly focused on HF methods to ensure success from that perspective. However, the development of across-the-board strategies that can address other critical factors is necessary. No previous scientific research has outlined and addressed the problems considering the QSR and the needs of key stakeholders. For that purpose, this effort presents a narrative review of how the HF requirement for medical devices and combination products developed, as well as the issues and the interventions that have taken place to address the bottlenecks. Some essential considerations such as notorious knowledge-based and process-based gaps are discussed. Similarly, because of the demands of a changing QSR, attention is brought to the need to align key stakeholders, namely manufacturers and HF service providers (HFSPs). Also, the development of an industry (HFSPs) maturity assessment tool and future research for that purpose are proposed.

Get full access to this article

View all access options for this article.

References

AAMI. (2014). AAMI TIR50 Post-market surveillance of use error management.

Andersen

E. S.

Jessen

S. A.

(2003). Project maturity in organisations. International Journal of Project Management, 21(6), 457–461. https://doi.org/10.1016/S0263-7863(02)00088-1

Baird

Binion

S. B.

Cammack

Del Paine

Gonzales

(2015). A roundtable discussion: Combination products: Twice the challenge? Biomedical Instrumentation and Technology. https://doi.org/10.2345/0899-8205-49.5.322

Basu

D. R.

(2013). Managing Quality in Projects. Gower.

Booz Allen Hamilton. (2016). Independent Assessment of FDA Device Review Process Management – Phase 2 Deliverable 6: Final Implementation Evaluation. Retrieved May 15, 2018, from https://www.fda.gov/downloads/ForIndustry/UserFees/MedicalDeviceUserFee/UCM484146.pdf

Burlington

D. B.

(1996). Human factors and the FDA’s goals: Improved medical device design. Biomedical Instrumentation and Technology.

Burnhill

M. S.

(1989). The rise and fall and rise of the IUD. The American Journal of Gynecologic Health.

Cafazzo

St-Cyr

(2012). From Discovery to Design: The Evolution of Human Factors in Healthcare. Healthcare Quarterly, 15(sp), 24–29. https://doi.org/10.12927/hcq.2012.22845

Campoe

K. R.

(2013). Medical Device Usability Analyses: An Integrative Review. Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care, 2(1), 123–130. https://doi.org/10.1177/2327857913021024

10.

Carvajal

C. L.

Moreno

A. M.

(2017). The maturity of usability maturity models. In Communications in Computer and Information Science (Vol. 770, pp. 85–99). https://doi.org/10.1007/978-3-319-67383-7_7

11.

Chagpar

Cafazzo

J. A.

(2010). Human Factors Recommendations and Testing Considerations for FDA Premarket Medical Device Submissions. Biomedical Instrumentation & Technology, 44(s1), 33–39. https://doi.org/10.2345/0899-8205-44.s1.33

12.

Chan

C. C.

Chow

Mckay

Fung

Ghani

Simpson

Blakemore

(2014). Challenges to Quality and Regulatory Requirements in the United States—Drugs, Medical Device, and Cell Therapy. In Chung Chow

Kwok

Bill

Fung

(Eds.), Therapeutic Delivery Solutions (First Edit, pp. 3–34). John Wiley & Sons, Inc.

13.

Chan

I. Z.

(2017). Product Development and Human Factors Considerations - Navigating the Halls of FDA-CDER.

14.

Chan

I. Z.

(2018). Workshop on Product Development and Human Factors Considerations in FDA/CDER: Human Factors Program Updates. In Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care. Boston, MA: HFES.

15.

Combination Products Coalition. (2014). Improving Patient Care through Better Combination Product Regulation. Washington, DC 20037.

16.

Cooke-Davies

T. J.

Arzymanow

(2003). The maturity of project management in different industries: An investigation into variations between project management models. International Journal of Project Management, 21(6), 471–478. https://doi.org/10.1016/S0263-7863(02)00084-4

17.

Cooper

J. B.

Newbower

R. S.

Kitz

R. J.

(1984). An analysis of major errors and equipment failures in anesthesia management: Considerations for prevention and detection. Anesthesiology. https://doi.org/10.1097/00000542-198401000-00008

18.

Cooper

J. B.

Newbower

R. S.

Long

C. D.

McPeek

(1978). Preventable anesthesia mishaps: A study of human factors. Anesthesiology. https://doi.org/10.1097/00000542-197812000-00004

19.

Crawford

J. Kent

. (2015). Project Management Maturity Model: Providing a Proven Path to Project Management Excellence. Auerbach Book.

20.

Crawford

J K.

(2006). The project management maturity model. Information Systems Management, 23(4), 50–58. https://doi.org/10.1201/1078.10580530/46352.23.4.20060901/95113.7

21.

Crosby

P. B.

(1979). Quality is free: The art of making quality certain. New York: New American Library. https://doi.org/10.2172/1025774

22.

Del Giudice

Hale

Johnston

. (2015). Development of a Scale for Quantifying a System’s Human Factors Readiness. Procedia Manufacturing, 3, 5192–5198. https://doi.org/10.1016/j.promfg.2015.07.580

23.

Enriquez

(2015). Califf Affirms Recommendations For Efficient Combination Product Reviews. Retrieved February 19, 2018, from https://www.meddeviceonline.com/doc/califf-affirms-recommendations-for-efficient-combination-product-reviews-0001

24.

FDA. (2003). Why did FDA harmonize its quality system regulation with the ISO standards? - UCM134625. FDA’s Website, 1–2.

25.

FDA. (2011). Understanding Barriers to Medical Device Quality. FDA Review Document, (October31st).

26.

FDA. (2015). Combination Product Review, Intercenter Consult Process Study. Retrieved February 27, 2018, from https://www.fda.gov/downloads/CombinationProducts/GuidanceRegulatoryInformation/UCM467128.pdf

27.

FDA. (2018). CDRH TPLC Transformation. Retrieved November 15, 2018, from https://www.advamed.org/sites/default/files/resource/cdrh_tplc_transformation.pdf

28.

FDA. (2019). Compliance Policy for Combination Product Postmarketing Safety Reporting Immediately in Effect Guidance for Industry and Food and Drug Administration Staff Compliance Policy for Combination Product Postmarketing Safety Reporting. FDA Guidance, (April 2019).

29.

FDA, CDER. (2017). Draft Guidance for Industry: Comparative Analyses and Related Comparative Use Human Factors Studies for a Drug-Device Combination Product Submitted in an ANDA. Retrieved from https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM536959.pdf

30.

FDA, CDER. (2018). Guidance Agenda: New & Revised Draft Guidances CDER Plans to Publish During Calendar Year 2018.

31.

FDA, CDER, CBER. (2017). Draft Guidance: Considerations in Demonstrating Interchangeability With a Reference Product Guidance for Industry. Retrieved April 25, 2018, from https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM537135.pdf

32.

FDA, CDRH. (n.d.). Quality System (QS) Regulation/Medical Device Good Manufacturing Practices. Retrieved October 16, 2018, from https://www.fda.gov/medicaldevices/deviceregulationandguidance/postmarketrequirements/qualitysystemsregulations/

33.

FDA, CDRH. (2000). Medical Device Use-Safety: Incorporating Human Factors Engineering into Risk Management. Guidance for Industry and FDA Premarket and Design Control Reviewers, 2–33.

34.

FDA, CDRH. (2011). Applying Human Factors and Usability Engineering to Optimize Medical Device Design. FDA Guidance for Industry, (301), 1–37. https://doi.org/10.1177/1071181311551334

35.

FDA, CDRH. (2016a). Applying Human Factors and Usability Engineering to Medical Devices - Guidance for Industry and Food and Drug Administration Staff. Retrieved from https://www.fda.gov/media/80481/download

36.

FDA, CDRH. (2016b). Draft Guidance - List of Highest Priority Devices for Human Factors Review. Retrieved February 19, 2018, from https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-meddev-gen/documents/document/ucm484097.pdf

37.

FDA, CDRH. (2018). Quality and Compliance (Medical Devices) - Case for Quality. Retrieved December 22, 2018, from https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/MedicalDeviceQualityandCompliance/ucm378185.htm

38.

FDA, CDRH. (2019). CDRH Reports - Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health. Retrieved February 21, 2019, from https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHReports/ucm604500.htm

39.

FDA, CDRH, CBER. (2018). Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program - Draft Guidance for Industry and Food and Drug Administration Staff. Retrieved October 24, 2018, from https://www.fda.gov/media/114034/download

40.

FDA, CDRH, CDER, CBER, & OCP. (2016). Draft Guidance Human Factors Studies and Related Clinical Study Considerations in Combination Product Design and Development. Retrieved April 25, 2018, from https://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM484345.pdf

41.

FDA, OCP. (2017). Guidance for Industry and FDA Staff: Current Good Manufacturing Practice for Combination Products. Retrieved October 16, 2018, from http://www.fda.gov/oc/combination

42.

FDA Unified Agenda. (2018). Harmonizing and Modernizing Regulation of Medical Device Quality Systems. Retrieved November 14, 2018, from https://www.reginfo.gov/public/do/eAgendaViewRule?pubId=201804&RIN=0910-AH99

43.

Ferriter

(2011). Medical Device Recall Report FY 2003- FY 2012. Retrieved February 19, 2018, from http://fmdic.org/wp-content/uploads/2014/04/Medical-Device-Recall-Report-amf-2.pdf

44.

Ho (Patrick)

. (2010). Fixing a 510(K) Loophole: In Support of The Sound Devices Act of 2012.

45.

Hodsden

(2016). FDA Clarifies Human Factor Studies For Medical Device And Combination Product Design. Retrieved February 19, 2018, from https://www.meddeviceonline.com/doc/fda-clarifies-human-factor-studies-for-medical-device-and-combination-product-design-0001

46.

Horst

Caplan

Mauro

Karn

Samaras

(2015). Panel – Challenges in Supporting the Design of Products for Healthcare The Human Factors Consultant’s Perspective. Proceedings of the Human Factors and Ergonomics Society, 2015-Janua, 572–574. https://doi.org/10.1177/1541931215591125

47.

Humphrey

W. S.

(1999). Pathways to Process Maturity: The Personal Software Process and Team Software Process. SEI Interactive, 2(2), 1-17., (April 1998).

48.

IOM. (1999). To Err is Human: Building a Safer Health System. ( Kohn

L. T.

Corrigan

J. M.

Donaldson

M. S.

, Eds.), National Academy Press. Washington (DC): National Academies Press (US). https://doi.org/10.1017/S095026880100509X

49.

IOM. (2010). Public Health Effectiveness of the FDA 510 ( k ) Clearance Process: Balancing Patient Safety and Innovation: Workshop Report. National Academies Press (US) (Vol. 510). Washington (DC).

50.

IOM. (2011). Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket Performance and Other Select Topics: Workshop Report. Washington, D.C.: National Academies Press. https://doi.org/10.17226/13020

51.

Jokela

Lalli

(2003). Usability and CMMI. In CHI ’03 extended abstracts on Human factors in computing systems - CHI ’03 (p. 1010). https://doi.org/10.1145/765891.766121

52.

Jugdev

Moller

(2006). A retrospective look at our evolving understanding of project success. IEEE Engineering Management Review. https://doi.org/10.1109/EMR.2006.261387

53.

Kappes

C. M.

Kershner

J. R.

Morwick

T. M.

Corrigan

S. M.

(2017). Dose Accuracy, Injection Force, and Usability Assessment of a New Half-Unit, Prefilled Insulin Pen. Journal of Diabetes Science and Technology, 193229681773631. https://doi.org/10.1177/1932296817736316

54.

Kay

Story

Nguyen

(2011). Meet the Human Factors Pre-Market Review Team from FDA (HFES’11 Healthcare Technical Group Invited Address). In Proceedings of the Human Factors and Ergonomics Society Annual Meeting (Vol. 55, pp. 645–645). https://doi.org/10.1177/1071181311551132

55.

Lin

Isla

Doniz

Harkness

Vicente

K. J.

Doyle

D. J.

(1998). Applying human factors to the design of medical equipment: patient-controlled analgesia. Journal of Clinical Monitoring and Computing, 14(4), 253–263. https://doi.org/10.1023/A:1009928203196

56.

Mahony

M. C.

Patterson

Hayward

North

Green

(2015). Human factors engineering and design validation for the redesigned follitropin alfa pen injection device. Expert Opinion on Drug Delivery, 12(5), 715–725.

57.

MDIC. (2015). Quality System Maturity Model for Medical Devices-Medical Device Innovation Consortium (MDIC), (June), 1–37.

58.

MDIC. (2019). Case for Quality. Retrieved January 19, 2019, from https://mdic.org/program/case-for-quality/

59.

Merrill

R. A.

(1994). Regulation of Drugs and Devices: An Evolution. Health Affairs, 13(3), 47–69. https://doi.org/10.1377/hlthaff.13.3.47

60.

Mitchell

A. E.

Colvin

H. M.

French

M. G.

Shepherd

K. M.

Grossblat

Martinez

R. M.

(2011). Medical Devices and the Public’s Health: The FDA 510(k) Clearance Process at 35 Years. Public Health (Vol. 510). https://doi.org/10.17226/13150

61.

Mitchell

(2015). Five Steps to Maturity. The Keil Centre Limited.

62.

Mullaly

(2006). Longitudinal analysis of project management maturity. Project Management Journal, 36(3), 62–73.

63.

Nickleby HFE Ltd. (2002). Framework for assessing human factor capability. HSE Health & Safety Executive.

64.

Nieto-Rodriguez

Evrard

(2004). Boosting Business Performance through Programme and Project Management * Table of contents. PriceWaterhouseCoopers.

65.

Parise

(2019). ISO 14971 Update: What Changes Can Medical Device Manufacturers Expect? - Covering the specialized field of orthopedic product development and manufacturing. Retrieved from https://www.odtmag.com/issues/2019-04-01/view_columns/iso-14971-update-what-changes-can-medical-device-manufacturers-expect/48595

66.

Pasian

(2018). Project Management Maturity and Associated Modeling: A Historic, Process-Oriented View. In Silvius

Karayaz

(Eds.), Developing Organizational Maturity for Effective Project Management (p. 24). IGI Global.

67.

Pennypacker

J. S.

Grant

K. P.

(2003). Project Management Maturity: an Industry Benchmark. Project Management Journal, 34(1), 4–11.

68.

Pietzsch

J. B.

Aquino

L. M.

Yock

P. G.

Paté-Cornell

M. E.

Linehan

J. H.

(2007). Review of U.S. Medical Device Regulation. Journal of Medical Devices, 1(4), 283. https://doi.org/10.1115/1.2812429

69.

Rappel

Michael

Sherman

(2016). Developing a Consensus Voice: The Combination Products Policy Council. Retrieved March 15, 2018, from https://blogs.fda.gov/fdavoice/index.php/2016/08/piloting-an-improved-intercenter-consult-process/

70.

Rappel

Hunter

Alexandrow

Hair

Sherman

Califf

(2017). Case Study for Lean Management in the Public Sector: Improving Combination Product Review at the Food and Drug Administration. Clinical and Translational Science, 10(3), 124–127. https://doi.org/10.1111/cts.12441

71.

Rojas

K. M.

Cosler

Sharareh

Santos

(2019). Considering the Dynamics of FDA Human Factors Validation Requirement: Implications of Failure and Need to Ensure Project Success – A Conceptual Framework. In Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care. Chicago, IL: SAGE Publications.

72.

Santana Tapia

Daneva

Van Eck

. (2007). Developing an Inter-Enterprise Alignment Maturity Model: Research Challenges and Solutions.

73.

Sawyer

(2000). Medical device requirements, human factors, and the Food and Drug Administration (FDA). In Proceedings of the IEA 2000/HFES 2000 Congress (pp. 526–527). Santa Monica, CA: HFES.

74.

Sawyer

Aziz

K. J.

Backinger

C. L.

Beers

E. T.

Lowery

Sykes

S. M.

(1996). An introduction to human factors in medical devices (do it by design). FDA Guidance.

75.

Schmettow

Schnittker

Schraagen

J. M.

(2017). An extended protocol for usability validation of medical devices: Research design and reference model. Journal of Biomedical Informatics, 69, 99–114. https://doi.org/10.1016/J.JBI.2017.03.010

76.

Schmitt

S. M.

(2017). US FDA Device Center Pushes “Total Product Life Cycle” Concept; “Reorganization” Coming, Says Compliance Chief. Medtech Insight: Global Medical Technology News & Analysis.

77.

Sherwood-Jones

Earthy

Bowler

Taylor

Forster

(1999). A Human Factors Integration Capability Maturity Model. INCOSE International Symposium, 9(1), 1526–1532. https://doi.org/10.1002/j.2334-5837.1999.tb00341.x

78.

Silvius

Karayaz

(2018). Developing organizational maturity for effective project management. ( Silvius

Karayaz

, Eds.), Developing Organizational Maturity for Effective Project Management. IGI Global. https://doi.org/10.4018/978-1-5225-3197-5

79.

Vincent

C. J.

Niezen

O’Kane

A. A.

Stawarz

(2015). Can standards and regulations keep up with health technology? JMIR MHealth and UHealth, 3(2), e64. https://doi.org/10.2196/mhealth.3918

80.

Wechsler

(2017). Combination Products Raise New Manufacturing Challenges. Pharmaceutical Technology, 41(5), 14–15.

81.

Westhoff

(2003). The IUD in Evolution. Obstetrical & Gynecological Survey. https://doi.org/10.1097/00006254-199612000-00010

82.

Williams

Joffe

Slonim

(2016). Health Options Foreclosed: How the FDA Denies Americans the Benefits of Medical Research.

83.

Wiyor

Feng

Lin

(2018). Workshop on Human Factors and Usability Engineering in Medical Device Design & Development. In Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care. Boston, MA: HFES.

84.

York

S. S.

(1989). IUD litigation: the Planned Parenthood experience. The American Journal of Gynecologic Health, 3(3-S), 35–37.

85.

Zuckerman

D. M.

Brown

Nissen

S. E.

(2011). Medical device recalls and the FDA approval process. Archives of Internal Medicine, 171(11), 1006–1011. https://doi.org/10.1001/archinternmed.2011.30